Skip to main content

Advertisement

SpringerLink
Log in

Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Activity Score (ASDAS) with Bath Ankylosing Spondylitis Activity Disease Activity Index (BASDAI) and other clinical disease activity parameters in patients with axial psoriatic arthritis (axPsA). Patients with axPsA were recruited from Erciyes Spondyloarthritis Cohort (ESPAC) and Anatolian Group for the Assessment in Rheumatic Disease (ANGARD) cohort and were assessed for BASDAI, ASDAS, BASFI (Bath Ankylosing Spondylitis Functional Index), Ankylosing Spondylitis Quality of Life (ASQoL), and visual analog scale (VAS) pain. The discriminant ability of ASDAS-C-reactive protein (−CRP) and ASDAS-erythrocyte sedimentation rate (−ESR) was assessed using standardized mean differences between patients with high and low disease activity. Fifty-four patients with axPsA were included in the study. Both ASDAS scores showed good discriminative ability between high and low disease activity states. Both ASDAS versions and BASDAI had relatively high area under the curve (AUC) according to ASAS partial remission, patient and physician global assessments in receiver operating characteristic (ROC) curve analysis. There was no significant difference between AUC scores for the models that compared ASDAS-CRP and ASDAS-ESR with BASDAI for each individual definition of disease activity states. ASDAS versions and BASDAI showed good similar discriminative ability between high and low disease activity as reflected by the AUC analysis in axPsA. The cutoff values for inactive disease and high disease activity were relatively similar to predefined cutoff values for AS. Further, prospective validation is now required to identify the appropriate assessment tools and cutoff values in axPsA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zink A, Thiele K, Huscher D, Listing J, Sieper J, Krause A, Gromnica-Ihle E, von Hinueber U, Wassenberg S, Genth E, Schneider M, German Collaborative Arthritis C (2006) Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 33(1):86–90

    PubMed  Google Scholar 

  2. Marsal S, Armadans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology 38(4):332–337

    Article  CAS  PubMed  Google Scholar 

  3. Battistone MJ, Manaster BJ, Reda DJ, Clegg DO (1999) The prevalence of sacroilitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study. Skelet Radiol 28(4):196–201

    Article  CAS  Google Scholar 

  4. Gladman DD, Brubacher B, Buskila D, Langevitz P, Farewell VT (1992) Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study. Clin Invest Med 15(4):371–375

    CAS  PubMed  Google Scholar 

  5. Hanly JG, Russell ML, Gladman DD (1988) Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis 47(5):386–393

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Nas K, Karkucak M, Durmus B, Ulu MA, Karatay S, Capkin E, Ulusoy H, Gulkesen A, Sula B, Akgol G, Cevik R, Ozgocmen S (2013) The performance of psoriatic arthritis classification criteria in Turkish patients with psoriatic arthritis. Int J Rheum Dis. doi:10.1111/1756-185X.12158

    Google Scholar 

  7. Helliwell PS, Hickling P, Wright V (1998) Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis 57(3):135–140

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Perez Alamino R, Maldonado Cocco JA, Citera G, Arturi P, Vazquez-Mellado J, Sampaio-Barros PD, Flores D, Burgos-Vargas R, Santos H, Chavez-Corrales JE, Palleiro D, Gutierrez MA, Vieira-Sousa E, Pimentel-Santos FM, Paira S, Berman A, Moreno-Alvarez M, Collantes-Estevez E, Group R (2011) Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol 38(8):1656–1660. doi:10.3899/jrheum.101049

    Article  PubMed  Google Scholar 

  9. Mease PJ, Antoni CE, Gladman DD, Taylor WJ (2005) Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 64(2):ii49–54. doi:10.1136/ard.2004.034165

    PubMed Central  PubMed  Google Scholar 

  10. Lubrano E, Marchesoni A, Olivieri I, D’Angelo S, Spadaro A, Parsons WJ, Cauli A, Salvarani C, Mathieu A, Zaccara E, Ferrara N, Helliwell PS (2009) The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol 27(6):977–980

    CAS  PubMed  Google Scholar 

  11. Chandran V, Barrett J, Schentag CT, Farewell VT, Gladman DD (2009) Axial psoriatic arthritis: update on a longterm prospective study. J Rheumatol 36(12):2744–2750. doi:10.3899/jrheum.090412

    Article  PubMed  Google Scholar 

  12. Taylor WJ, Harrison AA (2004) Could the bath ankylosing spondylitis disease activity index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis? Arthritis Rheum 51(3):311–315. doi:10.1002/art.20421

    Article  PubMed  Google Scholar 

  13. Fernandez-Sueiro JL, Willisch A, Pertega-Diaz S, Tasende JA, Fernandez-Lopez JC, Villar NO, Galdo F, Blanco FJ (2010) Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis. Arthritis Care Res 62(1):78–85. doi:10.1002/acr.20017

    Article  Google Scholar 

  14. Eder L, Chandran V, Shen H, Cook RJ, Gladman DD (2010) Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis 69(12):2160–2164. doi:10.1136/ard.2010.129726

    Article  PubMed  Google Scholar 

  15. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. Arthritis Care Res 21(12):2281–2285

    CAS  Google Scholar 

  16. Yanik B, Gursel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24(1):41–47. doi:10.1007/s10067-004-0968-6

    Article  PubMed  Google Scholar 

  17. Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62(1):20–26

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Duruoz MT, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, Tas N, Ozgocmen S, Yoleri O, Durmaz B, Oncel S, Tuncer T, Sendur O, Birtane M, Tuzun F, Bingol U, Kirnap M, Celik Erturk G, Ardicoglu O, Memis A, Atamaz F, Kizil R, Kacar C, Gurer G, Uzunca K, Sari H (2013) Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int 33(11):2717–2722. doi:10.1007/s00296-013-2796-y

    Article  CAS  PubMed  Google Scholar 

  19. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M (2001) Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 44(8):1876–1886. doi:10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F

    Article  CAS  PubMed  Google Scholar 

  20. DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44(3):837–845

    Article  CAS  PubMed  Google Scholar 

  21. Youden WJ (1950) Index for rating diagnostic tests. Cancer 3(1):32–35

    Article  CAS  PubMed  Google Scholar 

  22. Machado P, Landewe R, Lie E, Kvien TK, Braun J, Baker D, van der Heijde D, Assessment of SpondyloArthritis international S (2011) Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann Rheum Dis 70(1):47–53. doi:10.1136/ard.2010.138594

    Article  PubMed  Google Scholar 

  23. Queiro R, Belzunegui J, Gonzalez C, De DJ, Sarasqueta C, Torre JC, Figueroa M (2002) Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study. Clin Rheumatol 21(1):10–13

    Article  CAS  PubMed  Google Scholar 

  24. Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, van der Linden S, van der Heijde D, Assessment of SpondyloArthritis international S (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68(1):18–24. doi:10.1136/ard.2008.094870

    Article  CAS  PubMed  Google Scholar 

  25. van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewe R, Assessment of SpondyloArthritis international S (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68(12):1811–1818. doi:10.1136/ard.2008.100826

    Article  PubMed  Google Scholar 

  26. Aydin SZ, Can M, Atagunduz P, Direskeneli H (2010) Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis. Clin Exp Rheumatol 28(5):752–755

    CAS  PubMed  Google Scholar 

  27. van der Heijde D, Braun J, Dougados M, Sieper J, Pedersen R, Szumski A, Koenig AS (2012) Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial. Rheumatology 51(10):1894–1905. doi:10.1093/rheumatology/kes142

    Article  PubMed  Google Scholar 

  28. Xu M, Lin Z, Deng X, Li L, Wei Y, Liao Z, Li Q, Wei Q, Hu Z, Zhang Y, Lin Q, Huang J, Li T, Pan Y, Wu Y, Jin O, Yu B, Gu J (2011) The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-alpha inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China. Rheumatology 50(8):1466–1472. doi:10.1093/rheumatology/ker087

    Article  CAS  PubMed  Google Scholar 

  29. Fernandez-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estevez E, Mulero J, Munoz-Fernandez S, Zarco P, Carmona L, Group ES (2013) Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis. doi:10.1136/annrheumdis-2012-202976

    PubMed  Google Scholar 

  30. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39(4):561–577

    CAS  PubMed  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Erciyes University, Kayseri, 38039, Turkey

    Gamze Kılıç, Erkan Kılıç & Salih Özgöçmen

  2. Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Dicle University, Diyarbakir, Turkey

    Kemal Nas, Abdullah Zübeyir Dağlı & Remzi Çevik

  3. Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey

    Murat Karkucak & Erhan Çapkın

Authors
  1. Gamze Kılıç
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erkan Kılıç
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kemal Nas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Murat Karkucak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Erhan Çapkın
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Abdullah Zübeyir Dağlı
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Remzi Çevik
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Salih Özgöçmen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gamze Kılıç.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kılıç, G., Kılıç, E., Nas, K. et al. Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis. Clin Rheumatol 34, 515–521 (2015). https://doi.org/10.1007/s10067-014-2734-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2734-8

Keywords

Search

Navigation